Headlines
- Institutional investors have been adjusting their positions in Albemarle Co. (NYSE:ALB) in recent quarters.
- Several firms have expanded their stakes in the specialty chemicals company, including hedge funds and trust companies.
- The latest SEC filings provide insight into recent activity among major shareholders.
Institutional Holdings in Albemarle Co.
Caprock Group LLC recently increased its position in Albemarle, acquiring an additional 1,306 shares in the fourth quarter. The firm now holds 3,619 shares, with a total valuation of $313,000, as per the most recent SEC disclosure.
Other institutional investors have also adjusted their holdings. Quarry LP significantly increased its position in the company by 1,400.0% during the third quarter. After acquiring an additional 252 shares, Quarry LP now holds 270 shares, valued at $26,000.
Trust Co. of Vermont made a substantial move, raising its position by 606.5% in the fourth quarter. The firm now owns 325 shares, an increase of 279 shares, bringing its total valuation to $28,000.
New Entrants and Expanding Positions
Eastern Bank entered the scene with a new stake in Albemarle during the third quarter. The position, valued at $31,000, reflects continued institutional interest in the company’s operations.
First Community Trust NA expanded its stake by 55.0% in the fourth quarter, acquiring an additional 142 shares. The firm now owns 400 shares, valued at $34,000.
Meanwhile, MassMutual Private Wealth & Trust FSB increased its stake by 48.9% during the fourth quarter. With an additional 136 shares added, the firm now owns 414 shares, bringing the total valuation to $36,000.
Broader Institutional Participation
Hedge funds and institutional investors collectively own 92.87% of Albemarle’s outstanding shares. This level of ownership underscores the ongoing interest from financial institutions in the specialty chemicals sector.
Recent SEC filings provide valuable insights into the shifting landscape of institutional ownership in Albemarle Co. (NYSE:ALB). The company remains a notable presence in the specialty chemicals industry, with continuous adjustments among major shareholders shaping its investor base.